The US market for Hemostats and Sealants grew +5.6% YoY in Q319, a continued deceleration from +6.4% YoY in Q219, with fibrin sealants and absorbable hemostats driving the increase.
As reported in SmartTRAK’s Financial Dashboard, every manufacturer in the Hemostats and Sealants market experienced revenue growth in Q319. Leading the way was Becton Dickinson (BD), with Integra, Ethicon and Baxter all posting strong gains. The US Hemostats and Sealants market was up +5.6% YoY with all competitors posting gains for the quarter. Sealants continued their solid growth, up +6.5% YoY, with fibrin sealants leading the way. Absorbable hemostats resumed their leadership, contributing to the +5.1% YoY growth to...
Among the many topics covered in the complete, comprehensive Q319 US Hemostats and Sealants Market Recap* are:
- Ethicon’s Market Dominance Slips
- Absorbable Hemostats Take The Lead
- Biologic Sealants Continue To Rebound
- Important Events and Trials in Q319
The US Hemostats and Sealants market increased to $
in Q219, up +5.6% YoY. All competitors posted gains for the quarter. Sealants continued their solid growth, up +6.5% YoY, with fibrin sealants leading the way. Absorbable hemostats resumed their leadership, contributing to the +5.1% YoY growth to $.
In Q319, Ethicon continued to lead the overall US Hemostat and Sealants market, up + 4.1% YoY with $ in revenue and 47.0% share, rebounding from 40.7% share in Q219 as it recovers from its stumble in Q219. Baxter grew...
*The entire unedited article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.
